ZURN:SIXZurich Insurance Group Ltd Analysis
Data as of 2026-05-17 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Zurich Insurance (ZURN) trades at CHF 565.6, comfortably above its 20‑day (CHF 549.3) and 50‑day (CHF 548.7) moving averages but just shy of the 200‑day level (CHF 565.8), signaling short‑term momentum with a neutral longer‑term trend. Technicals are supportive – the RSI sits at 59, indicating no overbought pressure, while the MACD histogram is positive, delivering a bullish signal. The stock offers an attractive dividend yield of 5.3% with a payout ratio around 72%, and a strong ROE of 25%, underscoring solid profitability. However, the discounted cash‑flow model places fair value near CHF 298, far below the current price, suggesting the market may be overvalued despite a modest upside of ~2% in analyst targets.
Market Outlook
Short Term
< 1 yearKey Factors
- Price near resistance at CHF 572 limiting immediate upside
- Bullish MACD histogram supporting short‑term stability
- Overvaluation indicated by DCF fair value far below market price
Medium Term
1–3 yearsKey Factors
- Analyst target median (CHF 570) close to current price offering modest upside
- Strong dividend yield and ROE provide income and earnings resilience
- Revenue growth of ~9.5% and stable cash flow underpin earnings outlook
Long Term
> 3 yearsKey Factors
- Diversified global exposure mitigates single‑region risk
- Sustained profitability and dividend policy support total return
- Persistent overvaluation relative to DCF suggests caution despite solid fundamentals
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.